Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alloway

Showing results (351-360 of 360) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 360 results.
Trials|June 27, 2022
The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomesFergus J Caskey, Sunita Procter, Stephanie J MacNeill, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonalityTiffany Shi, Ashley R Burg, J Timothy Caldwell, et al.
The Journal of Clinical Investigation|May 25, 2023
Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonalityTiffany Shi, Ashley R Burg, J Timothy Caldwell, et al.
Nature|March 31, 2016
Revised stratigraphy and chronology for Homo floresiensis at Liang Bua in IndonesiaThomas Sutikna, Matthew W Tocheri, Michael J Morwood, et al.
Nature|June 10, 2016
Age and context of the oldest known hominin fossils from FloresAdam Brumm, Gerrit D van den Bergh, Michael Storey, et al.
Transplantation|February 17, 2017
Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in DirectionPhilip J OʼConnell, Dirk R Kuypers, Roslyn B Mannon, et al.
Kidney International Reports|February 14, 2022
One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) TrialMeghan Elizabeth Sise, David Seth Goldberg, Douglas Earl Schaubel, et al.
Kidney International|August 24, 2025
Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infectionPeter P Reese, Sumit Mohan, Douglas E Schaubel, et al.
Trials|October 18, 2024
Preparing for responsive management versus preparing for renal dialysis in multimorbid older people with advanced chronic kidney disease (Prepare for Kidney Care): Study protocol for a randomised controlled trialJo Worthington, Alexandra Soundy, Jessica Frost, et al.
Journal of the American Society of Nephrology : JASN|August 27, 2020
Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus InfectionMeghan E Sise, David S Goldberg, Jens J Kort, et al.
Pageof 36

Showing results (351-360 of 360) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 360 results.
Trials|June 27, 2022
The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomesFergus J Caskey, Sunita Procter, Stephanie J MacNeill, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonalityTiffany Shi, Ashley R Burg, J Timothy Caldwell, et al.
The Journal of Clinical Investigation|May 25, 2023
Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonalityTiffany Shi, Ashley R Burg, J Timothy Caldwell, et al.
Nature|March 31, 2016
Revised stratigraphy and chronology for Homo floresiensis at Liang Bua in IndonesiaThomas Sutikna, Matthew W Tocheri, Michael J Morwood, et al.
Nature|June 10, 2016
Age and context of the oldest known hominin fossils from FloresAdam Brumm, Gerrit D van den Bergh, Michael Storey, et al.
Transplantation|February 17, 2017
Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in DirectionPhilip J OʼConnell, Dirk R Kuypers, Roslyn B Mannon, et al.
Kidney International Reports|February 14, 2022
One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) TrialMeghan Elizabeth Sise, David Seth Goldberg, Douglas Earl Schaubel, et al.
Kidney International|August 24, 2025
Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infectionPeter P Reese, Sumit Mohan, Douglas E Schaubel, et al.
Trials|October 18, 2024
Preparing for responsive management versus preparing for renal dialysis in multimorbid older people with advanced chronic kidney disease (Prepare for Kidney Care): Study protocol for a randomised controlled trialJo Worthington, Alexandra Soundy, Jessica Frost, et al.
Journal of the American Society of Nephrology : JASN|August 27, 2020
Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus InfectionMeghan E Sise, David S Goldberg, Jens J Kort, et al.
Pageof 36